First Affiliated Hospital Of Wenzhou Medical University
Clinical trials sponsored by First Affiliated Hospital Of Wenzhou Medical University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a cancer drug slow lung scarring? new trial tests anlotinib for IPF Results expected Sep 2026 (estimated)
- Can AI predict who will respond to liver cancer drugs? Results expected Dec 2026 (estimated)
- Common nausea pill may tame immunotherapy's harsh side effects in liver cancer Results expected Dec 2026 (estimated)
- Radiation plus Chemo-Immunotherapy shows promise in High-Risk breast cancer trial Results expected Dec 2026 (estimated)
- New combo aims to slow lung scarring in IPF patients Results expected Mar 2027 (estimated)
-
One small incision vs several: robotic stomach cancer surgery put to the test
Cure Not yet recruitingResearchers are comparing two ways of performing robotic surgery to remove stomach cancer: a single-port approach and a standard multi-port approach. The trial enrolls 212 adults with stomach cancer that can be removed with distal gastrectomy. The main question is whether the sin…
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Cure
Last updated Sep 20, 2026 00:00 UTC
-
Gene therapy shots aim to save legs from amputation in diabetes
Disease control Not yet recruitingResearchers are testing whether seltoplasmid, a gene therapy injected into the calf muscle, can improve outcomes for people with type 2 diabetes who have poor blood flow to the foot and a non-healing ulcer. All participants first undergo a standard procedure to restore blood flow…
Phase 4 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Sep 20, 2026 00:00 UTC
-
Testing whether beta-blockers can be dropped once mavacamten steadies a thickened heart
Disease control Not yet recruitingResearchers are testing whether adults with obstructive hypertrophic cardiomyopathy can safely taper off beta-blockers after their heart condition has stabilized on mavacamten. The trial enrolls 286 people aged 18 to 75 who have been on a stable dose of mavacamten and one beta-bl…
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New hope for tough bladder cancer: immune drug plus chemo combo enters trial
Disease control Not yet recruitingThis study tests whether adding chemotherapy drugs (gemcitabine and mitomycin C) directly into the bladder alongside an immune-boosting drug (toripalimab) works better than toripalimab alone for people with a high-risk bladder cancer that did not respond to standard BCG therapy. …
Phase 2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Timing matters: study tests if starting gout drug during a flare is safe
Disease control Not yet recruitingThis study compares starting dotinurad, a urate-lowering drug, during an acute gout flare versus waiting until the flare resolves. About 142 adults with gout will be randomly assigned to one of two timing schedules. Researchers will measure how quickly the flare resolves and whet…
Phase 4 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New combo aims to slow lung scarring in IPF patients
Disease control Not yet recruitingThis phase 2 trial tests whether adding dextromethorphan to the standard drug nidanib helps people with idiopathic pulmonary fibrosis (IPF). About 60 adults aged 40 and older will take either the combo or nidanib alone for 12 weeks. The main goal is to see if lung function (FVC) …
Phase 2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New cell therapy takes aim at Hard-to-Treat cancers
Disease control Not yet recruitingThis early-stage trial tests an experimental treatment called CBG131 for adults with advanced stomach or pancreatic cancer that has a specific marker (CLDN18.2). The therapy uses a patient's own immune cells, modified in a lab to target and attack cancer cells. The main goals are…
Early phase 1 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
High-Tech knee surgery aims to beat arthritis pain
Disease control Not yet recruitingThis trial tests a new surgical system for knee osteoarthritis that uses 3D planning, custom guides, and augmented reality to improve alignment and reduce pain. About 150 people aged 40-70 with mild-to-moderate knee arthritis will be assigned to either the new system or tradition…
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Stomach-Saving surgery could help cancer patients keep weight on
Disease control Not yet recruitingThis study compares a new, less invasive surgery that removes only the cancerous upper part of the stomach to the standard full stomach removal. The goal is to see if the new approach helps patients lose less weight one year after surgery. The trial will enroll 120 adults with ea…
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Radiation plus Chemo-Immunotherapy shows promise in High-Risk breast cancer trial
Disease control Not yet recruitingThis study tests whether adding targeted radiation (SBRT) to standard chemotherapy and immunotherapy before surgery can improve outcomes for people with a common, high-risk breast cancer type (HR+/HER2-). About 302 participants will be randomly assigned to receive either chemo-im…
Phase 2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Timing is everything: new trial seeks to boost lung cancer treatment by rescheduling immunotherapy
Disease control Not yet recruitingThis clinical trial is testing whether giving immunotherapy a few days after chemotherapy, instead of on the same day, can improve outcomes for people with advanced non-small cell lung cancer. The study will enroll 246 adults and compare three different timing schedules, includin…
Phase 1/2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New surgical approach for rectal cancer in women aims to reduce bleeding
Disease control Not yet recruitingThis trial compares two surgical techniques for removing rectal cancer in women. The standard method cuts the peritoneum slightly above its lowest point, while the new method cuts exactly at the lowest point. Researchers believe the new technique may reduce blood loss and protect…
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New hope for Crohn's scarring: risankizumab vs ustekinumab in major trial
Disease control Not yet recruitingThis Phase 3 trial will test two drugs, risankizumab and ustekinumab, in 260 adults with fibrostenotic Crohn's disease—a form where the bowel becomes scarred and narrow. The study compares how well each drug prevents further scarring over three years. Participants will receive ei…
Phase 3 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 26, 2026 18:29 UTC
-
Heart patients: when is the best time for stent placement before other surgery?
Disease control Not yet recruitingThis study looks at 140 heart disease patients who also need a non-emergency surgery. Half will get a heart artery-opening procedure (PCI) before their surgery, and half will have it after. The goal is to see which timing leads to fewer heart attacks, deaths, or repeat procedures…
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 26, 2026 17:49 UTC
-
Could ozempic help men become fathers? new trial investigates
Disease control Not yet recruitingThis study tests whether two popular weight-loss drugs, semaglutide and tirzepatide, can improve sperm quality and help obese men have children naturally. About 180 men will receive either lifestyle advice, semaglutide, or tirzepatide for 32 weeks. Researchers will measure change…
Phase 2 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 26, 2026 17:30 UTC
-
New hope for rare nerve disease: can a biologic drug cut steroid use?
Disease control Not yet recruitingThis study tests a drug called inebilizumab combined with a fast steroid taper in 25 people newly diagnosed with neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease that attacks the optic nerves and spinal cord. The goal is to see if this approach can reduce…
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 26, 2026 15:16 UTC
-
Could a 12-week steroid course be enough for kidney disease?
Disease control Not yet recruitingThis study compares a 12-week steroid course to the standard 24-week course for adults with steroid-sensitive nephrotic syndrome, a kidney condition that causes protein leakage and swelling. Researchers want to see if the shorter treatment can keep the disease from coming back ju…
Phase 4 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Disease control
Last updated Jun 26, 2026 12:59 UTC
-
Could a nasal tube replace a temporary ileostomy after rectal cancer surgery?
Prevention Not yet recruitingResearchers are testing whether a nasal catheter that diverts stool from the small intestine can prevent leaks after surgery for mid to low rectal cancer. The trial compares this catheter approach with a standard protective ileostomy, a temporary opening in the abdomen to divert …
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Prevention
Last updated Sep 17, 2026 00:00 UTC
-
Could a simple tablet stop epilepsy after a stroke?
Prevention Not yet recruitingThis study tests whether a tablet called edaravone dexborneol can prevent epilepsy in people who have had a stroke and are at high risk. About 160 adults will receive either the tablet or a placebo for three months, starting within 48 hours of their stroke. Researchers will track…
Phase 3 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Prevention
Last updated Jun 27, 2026 12:36 UTC
-
AI on your phone could stop diabetic foot ulcers before they start
Prevention Not yet recruitingThis study tests whether digital tools, including AI image analysis, can help prevent foot ulcers in people with diabetes at high risk. Over 1,500 participants will be assigned to standard care or one of two digital care programs with different levels of support. The goal is to s…
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
Can leaving a sliver of tooth root save your smile after an implant?
Symptom relief Not yet recruitingResearchers compare two methods for replacing a missing front upper tooth with an implant right after extraction. One method, the Socket-Shield technique, leaves a thin piece of the tooth root in place to help protect the jawbone and gums. The other method uses the standard appro…
Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Symptom relief
Last updated Sep 18, 2026 00:00 UTC